What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Cell Passaging: Principles, Protocols, and Pitfalls

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

What Is Cell Passaging?

Definition and Terminology

Cell passaging, also termed subculturing, is the process of transferring a portion of cells from an established culture into fresh growth medium to maintain logarithmic-phase growth and prevent senescence or overgrowth. When cells are cultured ex vivo, they consume nutrients, produce metabolic waste, and proliferate until they reach a density that halts division. Passaging interrupts this trajectory by diluting the cell population and replenishing the medium, thereby resetting the culture to a permissive growth state.

The terminology distinguishes several related operations. Passage number refers to the cumulative number of times a culture has been subcultured since its isolation from the primary source. Split ratio describes the fraction of cells transferred—for example, a 1:4 split means one-quarter of the harvested cells are seeded into a new vessel. Seeding density is the number of viable cells plated per unit area or volume, typically expressed as cells per cm² for adherent cultures or cells per mL for suspension cultures. Confluency describes the percentage of the growth surface covered by adherent cells, with 100% confluency indicating a complete monolayer.

Why Passaging Is Essential

Continuous cell growth in vitro is an artificial condition. In vivo, cells exist within a three-dimensional tissue microenvironment where proliferation is tightly regulated by growth factors, cell–cell contacts, and extracellular matrix signaling. When cells are removed from this context and placed in a plastic dish with nutrient-rich medium, they proliferate without the normal constraints of tissue architecture. However, this proliferation is self-limiting: as cells approach confluence, nutrient depletion, waste accumulation, and contact-mediated growth arrest combine to slow or halt division.

Passaging serves three essential functions. First, it prevents contact inhibition from arresting the culture in a quiescent G0 state, from which recovery can be slow and heterogeneous. Second, it maintains cells in the exponential growth phase, where metabolic activity and protein expression are most uniform across the population. Third, it prevents the accumulation of dead cells and metabolic byproducts—particularly lactate and ammonia—that acidify the medium and create a cytotoxic environment. Without routine passaging, cultures undergo progressive deterioration characterized by vacuolization, detachment, and eventual cell death.

The Biology Behind Passaging

Cell Cycle and Proliferation

Mammalian cell proliferation is governed by the cell cycle, a tightly ordered sequence of events comprising four phases: G1 (gap 1), S (DNA synthesis), G2 (gap 2), and M (mitosis). Progression through these phases is driven by cyclin-dependent kinases (CDKs), whose activity is regulated by cyclin binding, phosphorylation, and CDK inhibitors such as p21 and p27. In G1, cells integrate extracellular signals—growth factors, nutrient availability, and adhesion cues—to decide whether to commit to another division cycle or exit into quiescence (G0).

In culture, cells in exponential growth phase exhibit a characteristic distribution across cell cycle phases, with the majority in G1. When passaged, the mechanical and enzymatic disruption of cell–cell and cell–matrix adhesions transiently activates stress signaling pathways, including p38 MAPK and JNK. This triggers a brief G1 delay as cells re-establish adhesion and re-engage integrin-mediated survival signals. Within hours of seeding, cells attach, spread, and re-enter the cell cycle. The lag phase following passaging—typically 6–24 hours depending on cell type—reflects this recovery period.

The decision to divide is also influenced by the restriction point in late G1, beyond which cells no longer require exogenous growth factors to complete the cycle. Cells that have passed the restriction point are committed to division regardless of subsequent growth factor withdrawal. This explains why passaging into fresh serum-containing medium is most effective at stimulating proliferation: serum provides the mitogenic signals—platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and insulin-like growth factor (IGF)—required to drive cells past the restriction point.

Contact Inhibition and Density Limitation

Contact inhibition is a density-dependent phenomenon whereby cells cease proliferation upon establishing extensive cell–cell contacts. The molecular basis involves the Hippo signaling pathway, a kinase cascade that regulates the transcriptional co-activators YAP and TAZ. When cells are sparse, YAP/TAZ translocate to the nucleus and promote expression of proliferative genes. As cell density increases, cell–cell contacts activate the Hippo pathway, leading to phosphorylation and cytoplasmic sequestration of YAP/TAZ, thereby suppressing proliferation.

In addition to Hippo signaling, contact inhibition involves the tumor suppressor p53 and its downstream target p21. High cell density stabilizes p53, which upregulates p21, a CDK inhibitor that blocks G1/S progression. The net effect is a G1 arrest that maintains cell viability while preventing further division. This arrest is reversible: if cells are passaged to lower density, the contact inhibition signals are relieved, and cells re-enter the cell cycle.

The practical consequence is that cells must be passaged before reaching full confluence. For most adherent cell lines, passaging at 70–90% confluence is optimal. Beyond this point, cells begin to exhibit contact inhibition, and the culture becomes heterogeneous—some cells arrested in G1, others still dividing, and a fraction undergoing apoptosis. This heterogeneity compromises experimental reproducibility, as the proportion of cycling cells varies between cultures.

Types of Cell Cultures and Their Passaging Requirements

Adherent vs Suspension Cultures

Adherent cells—including most epithelial, fibroblast, and endothelial lines—require a substrate for attachment and growth. They are cultured on tissue culture-treated plastic, which is modified by corona discharge to introduce negatively charged oxygen-containing groups that promote protein adsorption and cell attachment. Adherent cells must be enzymatically or mechanically detached before passaging. The most common enzyme is trypsin, a serine protease that cleaves peptide bonds C-terminal to arginine and lysine residues, thereby digesting the extracellular matrix proteins and cell–cell adhesion molecules that anchor cells to the surface.

Suspension cells—including many hematopoietic lines such as Jurkat, HL-60, and U937—grow freely in medium without attachment. They are passaged by simple dilution: a portion of the culture is transferred to fresh medium. Suspension cultures do not require enzymatic dissociation, which simplifies the procedure and eliminates trypsin-induced membrane damage. However, suspension cells are more sensitive to shear stress during pipetting and centrifugation, and they require regular agitation (typically on an orbital shaker) to prevent settling and localized nutrient depletion.

The choice between adherent and suspension culture has significant implications for passaging frequency and methodology. Adherent cells typically require passaging every 2–4 days, depending on growth rate and seeding density. Suspension cells may be passaged every 2–3 days or when the cell density reaches approximately 1–2 × 10⁶ cells/mL for most lines, though some fast-growing lines such as K562 can reach 2–3 × 10⁶ cells/mL before requiring dilution.

Primary vs Immortalized Cells

Primary cells are isolated directly from tissue and have a finite lifespan in culture. They undergo a limited number of population doublings—typically 20–60 for human cells—before entering replicative senescence, a state of irreversible growth arrest triggered by telomere shortening. The Hayflick limit, named after Leonard Hayflick who first described this phenomenon in human fibroblasts, defines this finite proliferative capacity. Primary cells are more physiologically relevant than immortalized lines but are more fastidious in their growth requirements and more sensitive to passaging-induced stress.

Immortalized cells, by contrast, have acquired the ability to divide indefinitely. This is typically achieved through expression of telomerase (hTERT), which maintains telomere length, or through viral oncogenes such as SV40 large T antigen, which inactivates p53 and Rb. Immortalized lines such as HeLa, HEK293, and CHO are robust, grow rapidly, and tolerate passaging well. However, they accumulate genetic and epigenetic changes over time, and their behavior may drift from the original tissue phenotype.

The passaging requirements differ substantially. Primary cells require gentler dissociation—often using trypsin neutralization with soybean trypsin inhibitor or using non-enzymatic dissociation buffers—and lower seeding densities to avoid stress-induced senescence. They also require specialized media supplemented with growth factors, such as epidermal growth factor (EGF) and fibroblast growth factor (FGF), which are not required by most immortalized lines. For detailed guidance on handling primary cultures, see Primary Cell Culture Guidelines and Primary and Secondary Cell Culture.

Step-by-Step Passaging Protocol

Preparation and Reagents

Before beginning any passaging procedure, assemble all reagents and equipment to minimize the time cells spend outside the incubator. The following reagents are required for adherent cell passaging:

Complete growth medium, pre-warmed to 37°C
Phosphate-buffered saline (PBS) without Ca²⁺ and Mg²⁺, pre-warmed to 37°C
Trypsin-EDTA solution (0.25% trypsin, 0.02% EDTA in PBS, or 0.05% trypsin for sensitive cells)
Trypsin neutralization solution (complete medium containing serum, or soybean trypsin inhibitor at 1 mg/mL)
Sterile pipettes, serological pipettes, and tissue culture vessels
Hemocytometer or automated cell counter
Trypan blue solution (0.4% w/v) for viability assessment

All work should be performed in a Class II biological safety cabinet with laminar flow. The cabinet surface should be wiped with 70% ethanol before and after use. Gloves should be changed if they contact non-sterile surfaces. For a comprehensive overview of aseptic technique and culture maintenance, refer to Animal Cell Culture.

Passaging Adherent Cells

The following protocol describes passaging of adherent cells grown in a 10 cm dish:

Examine the culture under an inverted microscope. Confirm that cells are in logarithmic growth and have reached 70–90% confluence. Check for signs of contamination (turbid medium, floating debris, unusual pH changes) or morphological abnormalities.

Remove the spent medium by aspiration using a sterile glass Pasteur pipette connected to a vacuum line. Tilt the dish to collect medium at one edge and aspirate completely.

Rinse the monolayer with 5–10 mL of PBS without Ca²⁺ and Mg²⁺. The absence of divalent cations is critical because Ca²⁺ and Mg²⁺ stabilize cell–cell adhesions and interfere with trypsin activity. Gently rock the dish to cover the entire surface, then aspirate the PBS. This rinse removes residual serum, which contains trypsin inhibitors such as α1-antitrypsin and α2-macroglobulin.

Add trypsin-EDTA (1–2 mL for a 10 cm dish) to cover the monolayer. Incubate at 37°C for 1–5 minutes. The exact time depends on cell type; fibroblasts detach within 1–2 minutes, while epithelial cells may require 3–5 minutes. Monitor detachment periodically by tapping the dish gently and observing under the microscope. Cells are ready when they appear rounded and begin to detach from the surface.

Neutralize the trypsin by adding 5–10 mL of complete medium containing serum. Serum contains abundant protease inhibitors that inactivate trypsin. Pipette the medium over the dish surface to dislodge remaining cells and collect the cell suspension in a sterile 15 mL conical tube.

Centrifuge the cell suspension at 200–300 × g for 5 minutes at room temperature. This pellets the cells while leaving trypsin and debris in the supernatant.

Aspirate the supernatant carefully, taking care not to disturb the cell pellet. Flick the tube to loosen the pellet, then resuspend in 5–10 mL of fresh complete medium by gentle pipetting. Avoid vigorous pipetting, which creates shear forces that damage cell membranes.

Count the cells using a hemocytometer or automated counter. Mix a small aliquot of the cell suspension with trypan blue (1:1 ratio) and load onto the hemocytometer. Count viable (unstained) cells in the four corner squares. Calculate the cell concentration using the formula: cells/mL = (average count per square) × dilution factor × 10⁴.

Seed the new culture vessel at the desired density. For a 1:4 split, transfer one-quarter of the cell suspension to a new 10 cm dish and add fresh medium to a final volume of 10 mL. Gently rock the dish to distribute cells evenly.

Place the dish in the incubator at 37°C in a humidified atmosphere of 5% CO₂. Loosen the lid slightly to allow gas exchange. Record the passage number and date on the dish.

Passaging Suspension Cells

Suspension cells are passaged by dilution, which is simpler than the adherent protocol:

Examine the culture under the microscope. Confirm that cells are in logarithmic growth and that the density is below the maximum recommended for the cell line (typically 1–2 × 10⁶ cells/mL).

Resuspend the cells by gentle pipetting or swirling to ensure a homogeneous suspension. Cells that have settled at the bottom of the flask must be evenly distributed before sampling.

Remove an aliquot of the cell suspension for counting. Determine the viable cell density using trypan blue exclusion.

Transfer the desired volume of cell suspension to a new flask containing fresh pre-warmed medium. For a 1:5 split, transfer one-fifth of the culture volume. Alternatively, calculate the volume needed to achieve a specific seeding density: volume to transfer (mL) = (desired seeding density × final volume) / current viable cell density.

Incubate the new culture at 37°C in 5% CO₂. If using a spinner flask or bioreactor, maintain agitation at the recommended speed (typically 50–100 rpm for small volumes). For details on scaling up suspension cultures, see Mammalian Cell Culture Bioreactor.

Determining Split Ratios and Seeding Density

Split Ratio

The split ratio determines how many new cultures can be generated from one parent culture and, more importantly, how long the new culture will take to reach the desired confluence. A 1:2 split means the culture is divided in half, and each half is seeded into a new vessel. This results in rapid regrowth to confluence (typically 1–2 days for fast-growing lines). A 1:10 split dilutes the culture more extensively, requiring 3–5 days to reach confluence.

The appropriate split ratio depends on the growth rate of the cell line and the desired passaging interval. Fast-growing lines such as HeLa and HEK293 can be split at 1:8 to 1:10 and passaged every 2–3 days. Slower-growing lines such as primary fibroblasts may require 1:2 to 1:4 splits and passaging every 4–7 days. The split ratio should be chosen so that cells reach 70–90% confluence at the next passage, avoiding both overgrowth and prolonged lag phases.

Seeding Density and Growth Curve

Seeding density—the number of viable cells plated per unit area—is a critical determinant of culture behavior. Too low a density results in a prolonged lag phase, as cells must condition the medium and establish autocrine growth factor signaling before proliferating. Too high a density leads to early contact inhibition and reduced total yield.

The optimal seeding density varies by cell type. For most adherent lines, a seeding density of 1–3 × 10⁴ cells/cm² is appropriate. For a 10 cm dish (surface area approximately 78.5 cm²), this corresponds to 0.8–2.4 × 10⁶ cells per dish. Suspension cells are typically seeded at 1–5 × 10⁵ cells/mL.

To determine the optimal seeding density for a specific cell line, generate a growth curve. Seed cells at multiple densities (e.g., 5 × 10³, 1 × 10⁴, 2 × 10⁴, and 5 × 10⁴ cells/cm²) and count cells daily for 7 days. Plot cell number versus time on a logarithmic scale. The exponential growth phase is the linear portion of this curve, and its slope gives the doubling time. The optimal seeding density is the lowest density that achieves exponential growth within 24 hours and reaches 80–90% confluence within the desired passaging interval.

Monitoring Cell Health and Viability

Viability Staining

Viability assessment before and after passaging is essential for maintaining culture quality. The most common method is trypan blue exclusion, which relies on the principle that viable cells with intact membranes exclude the dye, while dead cells with compromised membranes take it up and appear blue. The assay is simple: mix equal volumes of cell suspension and 0.4% trypan blue, incubate for 1–2 minutes, and count stained versus unstained cells in a hemocytometer. Viability is calculated as the percentage of unstained cells. For a detailed explanation of viability calculations, see Calculate Cell Viability and Measure Cell Viability.

Trypan blue has limitations. It cannot distinguish between apoptotic and necrotic cells, and it may overestimate viability in cultures with high proportions of early apoptotic cells that still exclude the dye. More sensitive methods include fluorescein diacetate (FDA) staining, which is converted to a green fluorescent product by esterases in viable cells, and propidium iodide (PI), which intercalates into DNA only in cells with disrupted membranes. For metabolic activity-based viability assessment, the MTT assay—which measures the reduction of yellow tetrazolium salt to purple formazan by mitochondrial dehydrogenases—is widely used. See Mtt Assay Cell Viability for protocol details.

A viability of ≥90% is generally acceptable for passaging. If viability falls below this threshold, the cause should be investigated before proceeding. Common causes include over-trypsinization, nutrient depletion, mycoplasma contamination, or excessive shear stress during pipetting.

Morphological Assessment

Morphological examination under an inverted microscope provides qualitative information about cell health that viability assays cannot capture. Healthy adherent cells exhibit characteristic morphology: fibroblasts are elongated and spindle-shaped; epithelial cells are polygonal and form cobblestone-like monolayers; endothelial cells are elongated and align in swirling patterns. Changes in morphology—rounding, vacuolization, granulation, or detachment—indicate cellular stress.

Phase-contrast microscopy at 100–200× magnification is sufficient for routine monitoring. Look for the following signs of distress:

Cytoplasmic vacuolization: indicates nutrient deprivation or toxin accumulation
Cell rounding and detachment: suggests over-trypsinization, pH imbalance, or apoptosis
Granular appearance: may indicate mycoplasma contamination
Irregular cell size and shape: suggests genetic drift or senescence
Floating cells in adherent cultures: normal in small numbers (dying cells), but excessive floating indicates problems

Common Pitfalls and Troubleshooting

Over-Trypsinization

Over-trypsinization is the most common and damaging error in adherent cell passaging. Prolonged exposure to trypsin damages cell surface proteins, including growth factor receptors, integrins, and adhesion molecules. This compromises cell attachment, reduces proliferation, and can trigger apoptosis. Cells that have been over-trypsinized appear small, rounded, and clumped, and they may fail to re-attach after seeding.

To avoid over-trypsinization, use the minimum trypsin concentration and incubation time required for detachment. For most cell lines, 0.05% trypsin-EDTA for 2–3 minutes at 37°C is sufficient. Monitor detachment every 30 seconds by tapping the dish and observing under the microscope. Stop the reaction as soon as cells begin to detach by adding serum-containing medium. For sensitive cells, consider using a gentler dissociation method such as 0.05% trypsin at room temperature or non-enzymatic cell dissociation buffer.

If over-trypsinization occurs, cells can often be rescued by immediate washing with fresh medium and allowing them to recover for 24 hours before passaging again. However, repeated over-trypsinization causes cumulative damage, and the culture may need to be replaced.

Contamination Risks

Contamination is the most serious threat to cell culture integrity. Bacterial contamination is typically visible within 24–48 hours as turbid medium, pH drop (yellow-orange color change in phenol red-containing medium), and small refractile particles under the microscope. Fungal contamination appears as filamentous structures or spores, often accompanied by a musty odor. Mycoplasma contamination is insidious—it produces no visible turbidity or pH change but alters cell metabolism, growth rate, and gene expression.

Prevention is the primary defense against contamination. Use sterile technique rigorously, including wiping all surfaces with 70% ethanol, using only sterile reagents, and performing all manipulations in a laminar flow hood. Add antibiotics (penicillin-streptomycin at 100 U/mL and 100 μg/mL, respectively) to the medium as a prophylactic measure, but note that antibiotics do not eliminate contamination and may mask low-level infections.

If contamination is suspected, discard the culture immediately and decontaminate the incubator and hood. Never attempt to rescue a contaminated culture, as this risks spreading the contamination to other cultures. For mycoplasma detection, use PCR-based assays or Hoechst 33258 staining, which reveals mycoplasma as punctate fluorescent bodies in the cytoplasm.

Drift in Cell Characteristics

Serial passaging leads to gradual changes in cell characteristics—a phenomenon known as genetic drift. This occurs through the accumulation of mutations, epigenetic changes, and selection for cells that grow fastest under culture conditions. Over time, cultures may lose differentiated functions, change morphology, or acquire altered drug sensitivity.

The rate of drift varies by cell type. Immortalized lines are more stable than primary cells, but even they change over extended passaging. HeLa cells, for example, have been passaged for decades and differ substantially from the original cervical carcinoma from which they were derived. To minimize drift, maintain a low passage number by freezing early-passage cells in liquid nitrogen and thawing fresh aliquots periodically. Limit the passage number for experiments—typically ≤20 passages for immortalized lines and ≤5–10 passages for primary cells.

Best Practices for Reproducible Passaging

Documentation

Meticulous documentation is essential for reproducible cell culture. Maintain a cell culture log that records for each passage:

Date and time of passaging
Cell line and passage number
Split ratio and seeding density
Viability and total cell count
Trypsin concentration and exposure time
Medium lot number and any supplements
Observations on morphology and growth characteristics

This documentation enables troubleshooting when problems arise and ensures that experiments are performed with cells at consistent passage numbers and growth states.

Standardization

Standardize all passaging procedures to minimize variability. This includes:

Consistent seeding density: Always seed at the same density for a given cell line and experiment
Consistent passaging interval: Passage at the same confluence (e.g., 80%) rather than on a fixed schedule
Consistent trypsinization: Use the same trypsin concentration, volume, and exposure time for each passage
Consistent medium: Use the same medium formulation and lot number where possible
Consistent incubation conditions: Maintain the same CO₂ concentration, temperature, and humidity

Standardization is particularly important for experiments that compare across time points or treatment conditions. Variability in passaging—even subtle differences in seeding density or trypsin exposure—can introduce noise that obscures experimental effects.

Frequently Asked Questions

What is cell passaging?

Cell passaging, also called subculturing, is the process of transferring a portion of cells from an established culture to fresh growth medium. This dilutes the cell population and provides fresh nutrients, allowing cells to continue proliferating in logarithmic phase rather than arresting due to contact inhibition or nutrient depletion.

Why do cells need to be passaged?

Cells need to be passaged because continuous growth in culture is self-limiting. As cells proliferate, they consume nutrients, produce metabolic waste, and establish cell–cell contacts that trigger contact inhibition. Without passaging, cells stop dividing, become stressed, and eventually die. Passaging resets the culture to a permissive growth state.

How often should cells be passaged?

The passaging interval depends on the cell type and seeding density. Fast-growing immortalized lines typically require passaging every 2–3 days, while slower-growing primary cells may be passaged every 4–7 days. The key is to passage before cells reach full confluence—typically at 70–90% confluence for adherent cells.

What is the standard cell passaging protocol?

The standard protocol for adherent cells involves: removing spent medium, rinsing with PBS, detaching cells with trypsin-EDTA, neutralizing trypsin with serum-containing medium, centrifuging, resuspending in fresh medium, counting cells, and seeding a new vessel at the desired density. Suspension cells are passaged by simple dilution into fresh medium.

What does passaging cells mean?

Passaging cells means subculturing—taking a portion of an existing culture and transferring it to fresh medium in a new vessel. This is a routine maintenance procedure that keeps cells in a healthy, proliferative state.

What is the meaning of cell passaging?

Cell passaging refers to the serial transfer of cells to fresh culture vessels with fresh medium. The term "passage" denotes each successive subculture, and the passage number tracks how many times a culture has been transferred since its establishment.

What are the steps for passaging cells?

The steps are: (1) examine the culture for health and confluence, (2) remove spent medium, (3) rinse with PBS, (4) detach cells with trypsin-EDTA, (5) neutralize trypsin with serum-containing medium, (6) centrifuge and resuspend, (7) count cells and assess viability, (8) seed new vessel at the desired density, and (9) incubate.

How do you passage cells?

To passage cells, you first ensure the culture is in logarithmic growth and at the appropriate confluence. For adherent cells, detach them enzymatically with trypsin, neutralize, pellet by centrifugation, resuspend in fresh medium, and seed into new vessels. For suspension cells, simply dilute the culture into fresh medium.

Key Takeaways

Cell passaging is the routine transfer of cells to fresh medium to maintain logarithmic growth and prevent contact inhibition, nutrient depletion, and waste accumulation.
The molecular basis of passaging involves the cell cycle, contact inhibition through the Hippo/YAP pathway, and the restriction point in late G1.
Adherent and suspension cells require different passaging methods—enzymatic dissociation versus simple dilution—and primary cells are more sensitive to passaging stress than immortalized lines.
The standard adherent passaging protocol involves PBS rinse, trypsin-EDTA detachment, serum neutralization, centrifugation, counting, and reseeding at a defined density.
Split ratios and seeding densities must be optimized for each cell line based on growth rate and desired passaging interval.
Viability assessment using trypan blue exclusion and morphological examination are essential for monitoring culture health before and after passaging.
Over-trypsinization, contamination, and genetic drift are the most common pitfalls; they are prevented by careful technique, rigorous aseptic practice, and limiting passage number.